Sign in
4

Changes in Ownership

abrdn Life Sciences Investors Filed Acc 0001510281-24-000328

10% owner bought 10,867 shares at an average $13.83 ($150,326)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Saba Capital Management, L.P. 10% owner 2024-06-12 Purchase +2,400 $13.88 $33,312 3,407,612 I
Saba Capital Management, L.P. 10% owner 2024-06-13 Purchase +8,467 $13.82 $117,014 3,416,079 I
Open-market purchases · 10,867 sh · avg $13.83 · $150,326
Loading xslF345X05/primary_doc.xml…